allon ptg & construction corp.

attn: robert swetnick esq.
3 park ave.
new york, new york 10016

NYS Entity Status
ACTIVE

NYS Filing Date
NOVEMBER 22, 2013

NYS DOS ID#
4491649

County
NASSAU

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC BUSINESS CORPORATION

Name History
2013 - ALLON PTG & CONSTRUCTION CORP.









Buffer

submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • Near The East River, Plans Emerge For NY’s Next Life Science Center
    By Ben Fidler - Monday Aug 21, 2017

    At a time when biotech incubators and shared spaces are beginning to multiply in Manhattan, work on what could rank among the city’s largest biotech centers—if it can all come together—is just getting underway. According to Paul Wexler, a longtime healthcare-focused real estate broker, construction should begin next year on what is being called the […]

    Source: Xconomy New York
  • 360 View: The Headache of Living Next to Endless Construction
    By RONDA KAYSEN - Friday Sep 15, 2017

    Construction scaffolding is a part of New York City’s streetscape. When it happens next door, developers sometimes pay neighbors for their trouble.

    Source: NYT > Home Page
  • Protagonist, Janssen Ink Development Deal for Crohn’s Disease Drug
    By Frank Vinluan - Tuesday May 30, 2017

    Protagonist Therapeutics’ work developing an inflammatory bowel disease drug that can be taken as a pill, rather than injected, now has fresh cash and the backing of a large pharmaceutical partner. Newark, CA-based Protagonist (NASDAQ: PTGX) has entered a partnership with Janssen Biotech to develop and commercialize its drug, PTG-200. Janssen is paying Protagonist $50 […]

    Source: Xconomy New York
  • New Development: Soft in the Middle, Splashy Up Top
    By STEFANOS CHEN - Friday Sep 15, 2017

    The luxury market in New York is pulling in two directions, with developers betting on big-ticket palatial aeries and million-dollar “starter” homes.

    Source: NYT > Home Page
  • “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
    By Ben Fidler - Wednesday Jun 7, 2017

    Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]

    Source: Xconomy VC, Deals, & Startups Feed
  • New York Becomes the City That Never Shuts Up
    By WINNIE HU - Wednesday Jul 19, 2017

    With noise complaints doubling over five years and once-quiet neighborhoods offering little refuge, the city is considering a law to help quiet the din.

    Source: NYT > Home Page